The store will not work correctly when cookies are disabled.
5-(3,4-Dihydroxy-pyrrolidin-2-yl)-2-methyl-furan-3-carboxylic acid ethyl ester
ID: ALA3350284
PubChem CID: 513279
Max Phase: Preclinical
Molecular Formula: C12H17NO5
Molecular Weight: 255.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([C@@H]2NC[C@@H](O)[C@H]2O)oc1C
Standard InChI: InChI=1S/C12H17NO5/c1-3-17-12(16)7-4-9(18-6(7)2)10-11(15)8(14)5-13-10/h4,8,10-11,13-15H,3,5H2,1-2H3/t8-,10+,11-/m1/s1
Standard InChI Key: HQEANUUDGAQVBA-DVVUODLYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
6.2326 -4.9303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2964 -5.8831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4212 -5.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5850 -6.2950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6070 -5.6459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0453 -6.2450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8236 -5.9954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5350 -7.1188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6070 -4.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7487 -7.3309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2994 -6.6320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1577 -3.4991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1716 -7.6388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4308 -4.1356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4367 -8.1048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4308 -5.7458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8052 -3.4075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6290 -3.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 1 1 0
4 2 1 1
5 1 2 0
6 5 1 0
7 4 1 0
8 4 1 0
9 1 1 0
10 8 1 0
11 7 1 0
12 9 2 0
8 13 1 6
14 9 1 0
10 15 1 6
16 5 1 0
17 14 1 0
18 17 1 0
2 6 1 0
10 11 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 255.27 | Molecular Weight (Monoisotopic): 255.1107 | AlogP: 0.13 | #Rotatable Bonds: 3 |
Polar Surface Area: 91.93 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.16 | CX Basic pKa: 7.93 | CX LogP: -0.22 | CX LogD: -0.87 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.66 | Np Likeness Score: 0.38 |
References
1. Moreno-Vargas AJ, Demange R, Fuentes J, Robina I, Vogel P.. (2002) Synthesis of [(2S,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-5-methylfuran-4-carboxylic acid derivatives: new leads as selective beta-galactosidase inhibitors., 12 (17): [PMID:12161128] [10.1016/s0960-894x(02)00397-9] |